Article
Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis…
Oxidative Medicine and Cellular Longevity · 2018 · Wenjing Shang, author Zhongdong Xie, author Fengying Lu, author Daoquan Fang, author Tianbin Tang, author Ruichun Bi, author Lingli Chen, author Lei Jiang, author Peeter Karihtala, Academic Editor
Key facts
| Title | Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer |
|---|---|
| First author | Wenjing Shang, author Zhongdong Xie, author Fengying Lu, author Daoquan Fang, author Tianbin Tang, author Ruichun Bi, author Lingli Chen, author Lei Jiang, author Peeter Karihtala, Academic Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Aug 6, 2018 |
| DOI | 10.1155/2019/9291683 |
| Product codes mentioned | LXG, NSU, PFX |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1